Actin Polymerization Toxins

Several bacteria release toxins that modify actin or proteins controlling its polymerization (1). A group of Clostridia spp. secrete binary toxins, whose most studied member is the C2 toxin released by Cl. botulinum. Botulinum C2 toxin is not neurospecific, as are botulinum neurotoxins, but it affects many nonneuronal cells (2). In the intestinal loop model, it induces an acute inflammatory reaction, characterized by the alteration of endothelia and a large increase in vascular permeability. At the same time, epithelial degeneration, exfoliation, and necrosis are also observed. In cultured cells, C2 causes rounding up, with formation of blebs, followed by cell death.

 Two polypeptide chains, I (55 kDa) and II (100 kDa), are needed for cell intoxication. Chain I catalyzes the ADP-ribosylation of Arg177 of soluble G-actin, a residue located in an area involved in protein-protein contact within the polymerized form, F-actin. The ADP-ribosylated G-actin binds to the barbed end of F-actin and prevents polymerization, whereas depolymerization at the opposite end is unaffected (3). This leads in vitro and in vivo to the disassembly of actin microfilaments, with cell rounding and release of focal adhesion plaques.

 Single-chain enzymes that catalyze the ADP-ribosylation of small G proteins are released by several bacteria (4). They cannot intoxicate cells because they lack the second polypeptide chain, but they are active after cell permeabilization or injection. C3 toxin is released by some strains of Cl. botulinum; it catalyzes the specific ADP-ribosylation of Asn-41 of Rho, a small GTP-binding protein involved in the regulation of actin polymerization. C3 induces the depolarization of F-actin, with rounding up and binucleation of injected cells. A different type of Rho modification is caused by cytotoxic necrotizing factors released by E. coli strains associated with gastroenteritis, urogenital infections, and septicemia (5). These factors cause cell ruffling, stress fiber formation, and multinucleation, by a covalent modification of Rho protein to lock it in its GTP-bound active form (6).

Clostridia spp. involved in the induction of diarrhea, associated with pseudomembraneous colitis, release in the intestine enterotoxins of very large dimensions (7). They are termed large clostridial toxins (LCTs) because of their size, which is in the range of 250 to 308 kDa. They are organized as A-B toxins, which are cleaved proteolytically into two polypeptide chains, A and B (see Toxins). The carboxyl-terminal part includes segments of 20 to 50 residues repeated 14 to 30 times, which are believed to mediate LCT binding to cell surface receptors. Such an organization in the absence of an oligomer of type B gives rise to a multivalent type of cell binding, as in the case of cholera toxin. Binding is followed by internalization of LCTs into coated vesicles and then into endosomes. By an unknown mechanism, the amino-terminal catalytic domain of the LCTs is released from the rest of the molecule and translocates into the cytosol, where it catalyzes the transfer of a sugar residue from the corresponding UDP derivative to an actin polymerization controlling protein (7, 8). All LCTs induce rounding of different cells in culture, but the effects of the various LCT toxins can be differentiated by staining actin filaments: Cl. difficile and Cl. novyi LCTs cause a breakdown of the F-actin microfilaments, whereas Cl. sordellii LCT induces the formation of filopodialike structures on the cell surface, with some membrane blebbing 7. This is related to the different protein(s) targeted by the LCTs. All of them modify a threonine residue of small GTP-binding protein(s) of the Ras superfamily, in such a way that its GTPase activity is unaltered but it can no longer interact with its effector molecule. This provides a further example of the ability of bacterial toxins to “choose” essential cell targets and to modify essential cell functions.

References

1. K. Aktories (1997) In Guidebook to Protein Toxins and Their Use in Cell Biology (R. Rappuoli and C. Montecucco, eds.), Sambrook and Tooze, Oxford University Press, Oxford. 

2. L. L. Simpson (1989) J. Pharmacol. Exp. Ther. 251, 1223–1228. 

3. M. Wille, I. Just, A. Wegner, and K. Aktories (1992) J. Biol. Chem. 267, 50–55. 

4. K. Aktories and A. Wegner (1992) Curr. Top. Microbiol. Immunol. 175, 115–131. 

5. A. Caprioli et al. (1984) Biochem. Biophys. Res. Commun. 118, 587–593. 

6. E. Oswald et al. (1994) Proc. Natl. Acad. Sci. USA 91, 3814–3818. 

7. C. von Eichel-Streiber, P. Boquet, M. Sauerborn, and M. Thelestam (1996) Trends Microbiol. 4375 –382,   .

8. I. Just et al. (1995) Nature 375, 500–503.